Lexicon Pharmaceuticals (LXRX) Beats Q4 Earnings Estimates by $0.03
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly earnings results on March 05, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share…
Read more
